For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Sangamo Therapeutics Inc (NASDAQ: SGMO) closed the day trading at $0.81 down -5.38% from the previous closing price of $0.86. In other words, the price has decreased by -$5.38 from its previous closing price. On the day, 4.88 million shares were traded. SGMO stock price reached its highest trading level at $0.8799 during the session, while it also had its lowest trading level at $0.81.
Ratios:
For a better understanding of SGMO, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.03 and its Current Ratio is at 1.03. In the meantime, Its Debt-to-Equity ratio is 1.23 whereas as Long-Term Debt/Eq ratio is at 1.23.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, RBC Capital Mkts on November 03, 2023, Downgraded its rating to Sector Perform and sets its target price to $2 from $6 previously.
On April 28, 2023, BofA Securities Downgraded its rating to Underperform which previously was Neutral and also lowered its target price recommendation from $5 to $1.50.
Wedbush Upgraded its Neutral to Outperform on February 27, 2023, while the target price for the stock was maintained at $16.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 26 ’23 when BIOGEN INC. sold 6,000,000 shares for $0.50 per share. The transaction valued at 3,000,000 led to the insider holds 17,652,466 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SGMO now has a Market Capitalization of 178438304 and an Enterprise Value of 170282080. For the stock, the TTM Price-to-Sale (P/S) ratio is 13.76 while its Price-to-Book (P/B) ratio in mrq is 7.13. Its current Enterprise Value per Revenue stands at 13.87 whereas that against EBITDA is -0.92.
Stock Price History:
Over the past 52 weeks, SGMO has reached a high of $1.48, while it has fallen to a 52-week low of $0.29. The 50-Day Moving Average of the stock is 32.13%, while the 200-Day Moving Average is calculated to be 35.86%.
Shares Statistics:
Over the past 3-months, SGMO traded about 14.14M shares per day on average, while over the past 10 days, SGMO traded about 6530200 shares per day. A total of 208.22M shares are outstanding, with a floating share count of 198.79M. Insiders hold about 4.53% of the company’s shares, while institutions hold 41.91% stake in the company. Shares short for SGMO as of 1722384000 were 19288733 with a Short Ratio of 1.36, compared to 1719532800 on 15507164. Therefore, it implies a Short% of Shares Outstanding of 19288733 and a Short% of Float of 9.32.
